CO2017005357A2 - Un proceso para la fabricación de idalopirdina - Google Patents

Un proceso para la fabricación de idalopirdina

Info

Publication number
CO2017005357A2
CO2017005357A2 CONC2017/0005357A CO2017005357A CO2017005357A2 CO 2017005357 A2 CO2017005357 A2 CO 2017005357A2 CO 2017005357 A CO2017005357 A CO 2017005357A CO 2017005357 A2 CO2017005357 A2 CO 2017005357A2
Authority
CO
Colombia
Prior art keywords
idalopirdine
manufacture
describes
preparation
pharmaceutically acceptable
Prior art date
Application number
CONC2017/0005357A
Other languages
English (en)
Inventor
Mikkel Fog Jacobsen
Ole Nielsen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2015/079209 external-priority patent/WO2016091997A1/en
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of CO2017005357A2 publication Critical patent/CO2017005357A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

RESUMEN “UN PROCESO PARA LA FABRICACIÓN DE IDALOPIRDINA” En la presente se describe un proceso para la preparación de idalopirdina y sales farmacéuticamente aceptables de esta.
CONC2017/0005357A 2014-12-12 2017-05-26 Un proceso para la fabricación de idalopirdina CO2017005357A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201400721 2014-12-12
PCT/EP2015/079209 WO2016091997A1 (en) 2014-12-12 2015-12-10 A process for the manufacture of idalopirdine

Publications (1)

Publication Number Publication Date
CO2017005357A2 true CO2017005357A2 (es) 2017-09-20

Family

ID=59011415

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0005357A CO2017005357A2 (es) 2014-12-12 2017-05-26 Un proceso para la fabricación de idalopirdina

Country Status (13)

Country Link
EP (1) EP3230265A1 (es)
JP (1) JP2017537128A (es)
KR (1) KR20170093821A (es)
CN (1) CN107001266A (es)
AU (1) AU2015359347A1 (es)
BR (1) BR112017012021A2 (es)
CA (1) CA2968770A1 (es)
CL (1) CL2017001466A1 (es)
CO (1) CO2017005357A2 (es)
IL (1) IL252471A0 (es)
MA (1) MA41148A (es)
MX (1) MX2017007510A (es)
RU (1) RU2017120216A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017010471B1 (pt) 2014-12-12 2024-02-27 Japan Tobacco Inc Compostos de di-hidropirimidin-2-ona, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042685A (en) * 1962-07-03 Process of making g-fluoro tryptamine
PE20081889A1 (es) * 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
TW201139370A (en) * 2009-12-23 2011-11-16 Lundbeck & Co As H Processes for the manufacture of a pharmaceutically active agent

Also Published As

Publication number Publication date
KR20170093821A (ko) 2017-08-16
AU2015359347A1 (en) 2017-06-08
CN107001266A (zh) 2017-08-01
MX2017007510A (es) 2017-08-22
JP2017537128A (ja) 2017-12-14
CA2968770A1 (en) 2016-06-16
RU2017120216A (ru) 2019-01-15
IL252471A0 (en) 2017-07-31
EP3230265A1 (en) 2017-10-18
MA41148A (fr) 2017-10-17
BR112017012021A2 (pt) 2018-03-13
CL2017001466A1 (es) 2018-01-05

Similar Documents

Publication Publication Date Title
NO2022046I1 (no) Berotralstat and pharmaceutically acceptable salts thereof
CU20160185A7 (es) Compuestos de heteroarilo para la inhibición de cinasa
TWD187539S (zh) 鞋之部分
TWD187540S (zh) 鞋之部分
IL263709A (en) Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use
BR112017004209A2 (pt) derivados de tetrahidronaftaleno que inibem a proteína mcl-1.
BR112017008659A2 (pt) ?métodos e compostos de agonista de gip?
TWD172100S (zh) 化粧瓶
TWD173737S (zh) 肌肉鍛鍊機器
CY1124521T1 (el) Σκευασματα αντισωματος anti-cd19
EP3096763A4 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
TWD173398S (zh) 瓶子之部分
TWD181115S (zh) 揚聲器之部分
EA201790627A1 (ru) СТИМУЛЯТОРЫ рГЦ
GT201700058A (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos
CL2016002338A1 (es) Uso de un compuesto que es ácido r-2-4-2-etoxi-3-4-trifluorometilfenoxipropil-tio-2-metilfenoxi acético, para el tratamiento de una enfermedad colestásica intrahepática .
AR101368A1 (es) Forma cristalina de sofosbuvir y proceso para su preparación
TWD181574S (zh) 首飾之部分
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
TWD181575S (zh) 首飾之部分
ECSP16086196A (es) Sales farmacéuticamente aceptables de enantiomeros de pirlindole para uso en medicina
CO2017005357A2 (es) Un proceso para la fabricación de idalopirdina
BR112016019079A2 (pt) método para a produção de dimetacrilato de glicerol de alta pureza.
EA201700060A1 (ru) Терапевтическое средство для кератоконъюнктивальных расстройств
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations